📰 Cel Life Sciences News
Cel Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cel Life Sciences. Real-time updates on events, politics, business and more.
April 18, 2024
RepliCel Announces Secured Loan Agreement VANCOUVER, BC, CANADA -April 17, 2024 - RepliCel Life Sciences Inc. , a company developing next-generation technologies in...
November 30, 2023
REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended September 30, 2023 and 2022 ...
October 24, 2023
REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended June 30, 2023 and 2022 ...
June 11, 2023
Alvopetro Energy Ltd. (V.ALV) hit a new 52-week high of $9.95 Friday. No news stories available today. Criterium Energy Ltd. (V.CEQ) hit a new 52-week high of 33 cents Friday. No news stories available today. DRI Healthcare Trust (T.DHT.UN) ...
June 9, 2023
Alvopetro Energy Ltd. (V.ALV) hit a new 52-week high of $9.95 Friday. No news stories available today. Criterium Energy Ltd. (V.CEQ) hit a new 52-week high of 33 cents Friday. No news stories available today. DRI Healthcare Trust (T.DHT.UN) ...
June 5, 2023
Alvopetro Energy Ltd. (T.ALV) hit a new 52-week high of $9.48 Monday. No news stories available today. Constellation Software Inc. (T.CSU) hit a new 52-week high of $2,779.30 Monday. No news stories available today. European Energy Metals Corp. ...
May 31, 2023
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the three months ended March 31, 2023 and 2022 Notice of No Auditor... | May 31, 2023
August 2, 2022
Independent Testing Performed by Innovacell Demonstrates the DermaPrecise Control Leads to Unparalleled Post-Injection Cell Survival and Viability ConsistencyVANCOUVER, BC / ACCESSWIRE / August 2, 2022
July 26, 2022
Independent dermatology research experts at Monasterium Laboratory GmbH tested, analyzed and validated various injection parameters using donated human tissueVANCOUVER, BC / ACCESSWIRE / July 26, 2022
May 24, 2021
RepliCel Launches Testing of Dermal Injector Units Initial units delivered and first phase of functional testing nearly complete VANCOUVER, BC, CANADA - 25 May 2021 - RepliCel Life Sciences Inc. (TSX.V:RP) (OTCPK:REPCF) (FRA:P6P2) (RepliCel or the Company), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has received the first units of its dermal injector and is nearing completion of the preliminary phase of functional testing requ...